Nippon India Pharma Fund(G)

285.71 -2.29 (-0.80%) NAV as on 08-Dec-22
52-Week High ( ) 313.66 (31-Dec-21)
52-Week Low ( ) 253.79 (17-Jun-22)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 4786.92
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return8.77-4.2423.7719.84
Category Avg8.20-4.0122.7014.17
Category Best-0.765.063.2019.46
Category Worst-6.89-3.39-6.39-4.00
SENSEX13.996.6915.66-
NIFTY13.786.5216.00-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries Ltd.Domestic Equities15.3
Cipla Ltd.Domestic Equities8.81
Dr. Reddy's Laboratories Ltd.Domestic Equities8.3
Lupin Ltd.Domestic Equities7.2
Abbott India Ltd.Domestic Equities5.47
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Equity and Equity related Instruments of companies other than those engaged in Pharma Sector020
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 09/12/2022 As on 09/12/2022

18449.30 (-0.86) 62195.27 (-0.60)

TOP GAINERS

Company Price Change Gain (%)
Rajdarshan Inds40.656.7519.91
Vaishali Pharma142.7020.2516.54

TOP LOSERS

Company Price Change Loss (%)
Prudent Corporate894.35-115.60-11.45
Vakrangee27.00-3.00-10.00

Portfolio Comparison

MUTUAL FUND ACTIVITY